CHARACTERIZATION OF A TRANSTHYRETIN-RELATED AMYLOID FIBRIL PROTEIN FROM CEREBRAL AMYLOID ANGIOPATHY IN TYPE-I FAMILIAL AMYLOID POLYNEUROPATHY

被引:17
|
作者
KAMETANI, F
IKEDA, S
YANAGISAWA, N
ISHI, T
HANYU, N
机构
[1] SHINSHU UNIV,SCH MED,DEPT MED NEUROL,MATSUMOTO,NAGANO 390,JAPAN
[2] NAGANO RED CROSS HOSP,DEPT NEUROL,NAGANO 380,JAPAN
[3] PSYCHIAT RES INST TOKYO,DEPT MOLEC BIOL,TOKYO 156,JAPAN
[4] PSYCHIAT RES INST TOKYO,DEPT ULTRASTRUCTURE,TOKYO 156,JAPAN
关键词
FAMILIAL AMYLOID POLYNEUROPATHY; CEREBRAL AMYLOID ANGIOPATHY; AMYLOID; TRANSTHYRETIN; AMYLOID FIBRIL PROTEIN; AMINO ACID SEQUENCE;
D O I
10.1016/0022-510X(92)90048-P
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recently, it has been reported that transthyretin (TTR)-immunoreactive amyloid deposition with cerebral amyloid angiopathy in central nervous system is a common pathological finding in type I familial amyloid polyneuropathy (FAP). In the present study, we performed isolation and sequence analysis of TTR-related amyloid fibril protein from the meninges of a patient with type I FAP. Purified major amyloid fibril protein had a molecular weight of 15 kDa. Complete sequence analysis revealed that this amyloid fibril protein was a variant TTR with a single amino acid substitution of methionine for valine at position 30. This variant TTR is a previously unrecognized as cerebrovascular amyloid fibril protein. Furthermore, the patients with type I FAP are well known to have the variant TTR in the serum. These suggest that cerebrovascular amyloid fibril protein in type I FAP may derive from a serum precursor.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 50 条
  • [1] TRANSTHYRETIN-TYPE CEREBRAL AMYLOID ANGIOPATHY IN TYPE-I FAMILIAL AMYLOID POLYNEUROPATHY
    USHIYAMA, M
    IKEDA, S
    YANAGISAWA, N
    ACTA NEUROPATHOLOGICA, 1991, 81 (05) : 524 - 528
  • [2] AMYLOID FIBRIL PROTEIN IN TYPE-I FAMILIAL AMYLOIDOTIC POLYNEUROPATHY IN JAPANESE
    TAWARA, S
    ARAKI, S
    TOSHIMORI, K
    NAKAGAWA, H
    OHTAKI, S
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1981, 98 (06): : 811 - 822
  • [3] Liver transplantation in transthyretin-related familial amyloid polyneuropathy
    Stangou, AJ
    Hawkins, PN
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 615 - 620
  • [4] Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
    Antoine Rousseau
    Emmanuel Barreau
    Julia Meney
    Zoia Mincheva
    Cécile Cauquil
    Marie Théaudin
    Marc Labetoulle
    David Adams
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [5] Cognitive impairment in transthyretin-related familial amyloid polyneuropathy
    Alves, P. N.
    Castro, V.
    Franco, A.
    Martins, I. P.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 142 - 143
  • [6] AMYLOID FIBRIL PROTEIN IN FAMILIAL AMYLOID POLYNEUROPATHY
    SHOJI, S
    OKANO, A
    NEUROLOGY, 1981, 31 (02) : 186 - 190
  • [8] Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathy
    Sekijima, Yoshiki
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 124 - 124
  • [9] Transthyretin related familial amyloid polyneuropathy
    Planté-Bordeneuve, V
    Said, G
    CURRENT OPINION IN NEUROLOGY, 2000, 13 (05) : 569 - 573
  • [10] AN OBSERVATIONAL STUDY ON TAFAMIDIS FOR TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY IN ITALY
    Cortese, A.
    Russo, M.
    Obici, L.
    Cavallaro, T.
    Fabrizi, G. M.
    Manganelli, F.
    Santoro, L.
    Luigetti, M.
    Sabatelli, M.
    Schenone, A.
    Grandis, M.
    Mauro, A.
    Pradotto, L. G.
    Mazzeo, A.
    Gentile, L.
    Piscosquito, G.
    Calabrese, D.
    Vita, G.
    Merlini, G.
    Pareyson, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S8 - S9